C-terminal heptapeptide of gastrin inhibits astrocytomas motility by interacting with a new gastrin binding site

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 1, 2002, Pages 274-282

  Pannequin, Julie ^a   Oiry, Catherine ^a   Morel, Caroline ^a   Kucharczak, Jérôme ^a   Camby, Isabelle ^a   Kiss, Robert ^a   Gagne, Didier ^a   Galleyrand, Jean Claude ^a   Martinez, Jean ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ[29-33]; G 7; GASTRIN DERIVATIVE; GASTRIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPTAPEPTIDE; PROTEIN C FOS; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER HORMONE THERAPY; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DRUG BINDING; DRUG BINDING SITE; GENETIC TRANSCRIPTION; HORMONE BINDING; HUMAN; HUMAN CELL; ISOTOPE LABELING; PARENCHYMA; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR CELL;

AMINO ACID SEQUENCE; ASTROCYTOMA; BINDING SITES; BRAIN NEOPLASMS; CELL DIVISION; CELL MOVEMENT; CYCLIC AMP; GASTRINS; GENES, FOS; HUMANS; INOSITOL PHOSPHATES; IODINE RADIOISOTOPES; ISOTOPE LABELING; KINETICS; LUCIFERASES; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SECOND MESSENGER SYSTEMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036088305     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.1.274     Document Type: Article

References (35)

1. Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: Involvement of the estrogen receptor
2. Tetrapeptide induces panic attacks in patients with panic disorder
3. Influence of gastrin on human astrocytic tumor cell proliferation
4. Dynamic characterization of glioblastoma cell motility
5. Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell lines
6. In vitro motility evaluation of aggregated cancer cells by means of automatic image processing
7. Gastrin and CCK related peptides
8. 11]gastrin(5-17), on binding to canine fundic mucosal cells and Jurkat cells
9. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolitic activity
10. Functional characterization of a human brain cholecystokinin-B receptor. Atrophic effect of cholecystokinin and gastrin
11. Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors
12. Interaction of CCK with pancreatic acinar cells
13. Cholecystokinin and gastrin are not equally sensitive to GTPγS at CCKB receptors: Importance of the sulfated tyrosine
14. Cell migration: A physically integrated molecular process
15. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization
16. JMV 1155: A novel inhibitor of glycine-extended progastrin-mediated growth of a human colon cancer in vivo
17. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase
18. Two brain cholecystokinin receptors: Implications for behavioral actions
19. International union of pharmacology. XXI. Structure, distribution and functions of cholecystokinin receptors
20. Cholecystokinin B receptor from human Jurkat lymphoblastic T cells is involved in activator protein-1-responsive gene activation
21. L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway
22. The third intracellular loop of the rat and mouse cholecystokinin-A receptors is responsible for different patterns of gene activation
23. Gastrin and CCK activate phospholipase C and stimulate pepsinogen release by interacting with two distinct receptors
24. Similar rates of phosphatidylinositol hydrolysis following activation of wild-type and truncated rat neurokinin-1 receptors
25. Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors
26. Gastrin, CCK, signaling and cancer
27. Growth-promoting effects of glycine-extended progastrin
28. Biology of gut cholecystokinin and gastrin receptors
29. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors
30. Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin
31. Gastrin induces c-Fos gene transcription via multiple signaling pathways
32. Gene structure of rat cholecystokinin type-A receptor
33. Molecular cloning, structural characterization and functional expression of the human substance P receptor
34. Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas
35. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression